DaVita Kidney Care has agreed to pay $389 million to resolve a whistle-blower's allegations that the company induced physicians to steer patients to its dialysis centers for the past decade with opportunities to profit by buying and selling stakes in clinics.
DaVita Kidney Care, the largest division of Denver-based DaVita HealthCare Partners, previously disclosed the sum in financial reports to the Securities and Exchange Commission and has now finalized the agreement with the U.S. Justice Department.
continue to read here
No comments:
Post a Comment